260 related articles for article (PubMed ID: 22996014)
1. New prognosis biomarkers identified by dynamic proteomic analysis of colorectal cancer.
Peng Y; Li X; Wu M; Yang J; Liu M; Zhang W; Xiang B; Wang X; Li X; Li G; Shen S
Mol Biosyst; 2012 Nov; 8(11):3077-88. PubMed ID: 22996014
[TBL] [Abstract][Full Text] [Related]
2. Proteome analysis and tissue microarray for profiling protein markers associated with lymph node metastasis in colorectal cancer.
Pei H; Zhu H; Zeng S; Li Y; Yang H; Shen L; Chen J; Zeng L; Fan J; Li X; Gong Y; Shen H
J Proteome Res; 2007 Jul; 6(7):2495-501. PubMed ID: 17542627
[TBL] [Abstract][Full Text] [Related]
3. Identification of differentially-expressed proteins between early submucosal non-invasive and invasive colorectal cancer using 2D-DIGE and mass spectrometry.
Zhang J; Song MQ; Zhu JS; Zhou Z; Xu ZP; Chen WX; Chen NW
Int J Immunopathol Pharmacol; 2011; 24(4):849-59. PubMed ID: 22230392
[TBL] [Abstract][Full Text] [Related]
4. Proteomic expression analysis of colorectal cancer by two-dimensional differential gel electrophoresis.
Alfonso P; Núñez A; Madoz-Gurpide J; Lombardia L; Sánchez L; Casal JI
Proteomics; 2005 Jul; 5(10):2602-11. PubMed ID: 15924290
[TBL] [Abstract][Full Text] [Related]
5. Proteomics-based identification of a group of apoptosis-related proteins and biomarkers in gastric cancer.
Bai Z; Ye Y; Liang B; Xu F; Zhang H; Zhang Y; Peng J; Shen D; Cui Z; Zhang Z; Wang S
Int J Oncol; 2011 Feb; 38(2):375-83. PubMed ID: 21165559
[TBL] [Abstract][Full Text] [Related]
6. Proteomic analysis of Tiam1-mediated metastasis in colorectal cancer.
Liu L; Zhao L; Zhang Y; Zhang Q; Ding Y
Cell Biol Int; 2007 Aug; 31(8):805-14. PubMed ID: 17376711
[TBL] [Abstract][Full Text] [Related]
7. [Preoperative molecular staging of colorectal cancers by CM10 ProteinChip and SELDI-TOF-MS analysis].
Xu WH; Chen YD; Hu Y; Yu JK; Wu XG; Jiang TJ; Zheng S; Zhang SZ
Zhonghua Zhong Liu Za Zhi; 2006 Oct; 28(10):753-7. PubMed ID: 17366787
[TBL] [Abstract][Full Text] [Related]
8. Stathmin, a new target of PRL-3 identified by proteomic methods, plays a key role in progression and metastasis of colorectal cancer.
Zheng P; Liu YX; Chen L; Liu XH; Xiao ZQ; Zhao L; Li GQ; Zhou J; Ding YQ; Li JM
J Proteome Res; 2010 Oct; 9(10):4897-905. PubMed ID: 20806969
[TBL] [Abstract][Full Text] [Related]
9. Preoperatively molecular staging with CM10 ProteinChip and SELDI-TOF-MS for colorectal cancer patients.
Xu WH; Chen YD; Hu Y; Yu JK; Wu XG; Jiang TJ; Zheng S; Zhang SZ
J Zhejiang Univ Sci B; 2006 Mar; 7(3):235-40. PubMed ID: 16502512
[TBL] [Abstract][Full Text] [Related]
10. Novel proteomic biomarker panel for prediction of aggressive metastatic hepatocellular carcinoma relapse in surgically resectable patients.
Tan GS; Lim KH; Tan HT; Khoo ML; Tan SH; Toh HC; Ching Ming Chung M
J Proteome Res; 2014 Nov; 13(11):4833-46. PubMed ID: 24946162
[TBL] [Abstract][Full Text] [Related]
11. A serum proteomic pattern for the detection of colorectal adenocarcinoma using surface enhanced laser desorption and ionization mass spectrometry.
Liu XP; Shen J; Li ZF; Yan L; Gu J
Cancer Invest; 2006 Dec; 24(8):747-53. PubMed ID: 17162557
[TBL] [Abstract][Full Text] [Related]
12. Profiling protein markers associated with lymph node metastasis in prostate cancer by DIGE-based proteomics analysis.
Pang J; Liu WP; Liu XP; Li LY; Fang YQ; Sun QP; Liu SJ; Li MT; Su ZL; Gao X
J Proteome Res; 2010 Jan; 9(1):216-26. PubMed ID: 19894759
[TBL] [Abstract][Full Text] [Related]
13. Proteomic profiling of hepatocellular carcinoma in Chinese cohort reveals heat-shock proteins (Hsp27, Hsp70, GRP78) up-regulation and their associated prognostic values.
Luk JM; Lam CT; Siu AF; Lam BY; Ng IO; Hu MY; Che CM; Fan ST
Proteomics; 2006 Feb; 6(3):1049-57. PubMed ID: 16400691
[TBL] [Abstract][Full Text] [Related]
14. Proteomic analysis of colorectal cancer metastasis: stathmin-1 revealed as a player in cancer cell migration and prognostic marker.
Tan HT; Wu W; Ng YZ; Zhang X; Yan B; Ong CW; Tan S; Salto-Tellez M; Hooi SC; Chung MC
J Proteome Res; 2012 Feb; 11(2):1433-45. PubMed ID: 22181002
[TBL] [Abstract][Full Text] [Related]
15. Proteomic-based analysis for identification of potential serum biomarkers in gallbladder cancer.
Tan Y; Ma SY; Wang FQ; Meng HP; Mei C; Liu A; Wu HR
Oncol Rep; 2011 Oct; 26(4):853-9. PubMed ID: 21687958
[TBL] [Abstract][Full Text] [Related]
16. Proteomic analysis of protein expression in human tonsillar cancer: differentially expressed proteins characterize human tonsillar cancer.
Roblick UJ; Bader FG; Hammarstedt L; Habermann JK; Hellman U; Becker S; Sundmacker A; Gemoll T; Zimmermann K; Auer G; Munck-Wikland E
Acta Oncol; 2008; 47(8):1493-501. PubMed ID: 18759147
[TBL] [Abstract][Full Text] [Related]
17. Proteomic analysis to identify biomarker proteins in pancreatic ductal adenocarcinoma.
Chung JC; Oh MJ; Choi SH; Bae CD
ANZ J Surg; 2008 Apr; 78(4):245-51. PubMed ID: 18366394
[TBL] [Abstract][Full Text] [Related]
18. Proteomic analysis shows down-regulations of cytoplasmic carbonic anhydrases, CAI and CAII, are early events of colorectal carcinogenesis but are not correlated with lymph node metastasis.
Wang N; Chen Y; Han Y; Zhao Y; Liu Y; Guo K; Jiang Y
Tumori; 2012 Nov; 98(6):783-91. PubMed ID: 23389367
[TBL] [Abstract][Full Text] [Related]
19. 2D-DIGE analysis of ovarian cancer cell responses to cytotoxic gold compounds.
Guidi F; Puglia M; Gabbiani C; Landini I; Gamberi T; Fregona D; Cinellu MA; Nobili S; Mini E; Bini L; Modesti PA; Modesti A; Messori L
Mol Biosyst; 2012 Apr; 8(4):985-93. PubMed ID: 22134777
[TBL] [Abstract][Full Text] [Related]
20. [Screen and identify of differential proteins expressed in the placenta of Down's syndrome].
Yan LY; Sun CJ; Wang X; Chen Y; Zhang WY
Zhonghua Fu Chan Ke Za Zhi; 2011 Mar; 46(3):161-6. PubMed ID: 21575446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]